Amoun Pharmaceuticals

Amoun's main businesses include the development, manufacturing, marketing, distribution, and export of various human pharmaceuticals and animal health products.Amoun has a strong product portfolio that provides a wide range of urgently needed drug treatments and therapies. With a robust product pipeline strategy, Amoun currently has over 30 new products at different stages of registration, carefully selected to meet many unmet therapeutic needs, such as highly prevalent diseases and other conditions of significant national interest. Amoun’s product portfolio and pipeline will continue to expand further in the coming years and will remain instrumental in driving growth and enhancing shareholder value.